Integrated Report

Overview

The report presents the company’s human health care philosophy, placing patient satisfaction before financial results. It reports consolidated FY2017 revenue of ¥600.1 billion and describes broad partnerships to expand innovation and access to medicines. ESG highlights include free DEC tablet provision for lymphatic filariasis, an accepted SBTi commitment, a B CDP Climate Change score, and joining the UN Global Compact.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2017-2018
Period: 1 April 2017 – 31 March 2018
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status
CDP score

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services